| Highlights
Include: |
Dr.
Alpesh Amin:
• 39.6 % of hospitalized critical care patients
did not receive anticoagulation during their hospital
stay.2
• DVT-related PE is the most common cause
of preventable hospital deaths.3
More people in the U.S. die each year from DVT/PE
complications than AIDS and breast cancer combined4
Dr. Steven Deitelzweig:
• In the study period, there was a 30 percent
increase in patients with VTE per 100,000 U.S.
Medicaid plan enrollees5
• African American males had the highest
overall observed prevalence rate with an increase
of 34 percent during the study period6
|
|
Dear
Healthcare Professional,
We invite you to review two
recent data presentations about the appropriate prophylaxis
of deep vein thrombosis, presented by
Dr. Alpesh Amin and Dr. Steven Deitelzweig.
In
the video, "Results of Two New Studies Demonstrate that
VTE Prevention is Not Occurring Across the Continuum of
Care,"
Dr. Alpesh Amin discusses data emphasizing the need for
venous thromboembolism prevention for patients in the hospital
as well as following discharge.
In the podcast, "New Study Reveals African American Males
Had Highest Rate of VTE," Dr. Steven Deitelzweig discusses
study data about the need for improved awareness and prevention
of venous thromboembolism across all ethnic groups. This
study showed that African Americans had the highest rate
of VTE.1
About the speakers:
Dr.
Alpesh Amin
is Executive Director, Hospitalist Program; Medical Director,
Anticoagulation Clinic and Vice Chair for Clinical Affairs
& Quality Department of Medicine at the University of California,
Irvine.
Dr. Amin is an active proponent of the hospitalist movement.
He has published in areas of hospital medicine, medical
education and quality outcomes in venous thromboembolism
prevention. Dr. Amin is a Fellow of the American College
of Physicians and Senior Fellow of the Society of Hospital
Medicine.
Dr. Steven Deitelzweig is System Chairman of the Department
of Hospital Medicine and Vice President of Medical Affairs
at the Ochsner Medical Center.
An extensive lecturer, Dr. Deitelzweig has presented regionally,
nationally and internationally on a variety of topics, such
as heart failure, deep vein thrombosis, pulmonary embolism,
acute coronary syndrome and anticoagulation. He is a Senior
Fellow and charter member for the Society of Hospital Medicine
and has been course director for the Ochsner/Emory University-sponsored
Southern Hospital Medicine meeting for 9 years. He is currently
the Vice President for the Gulf States Hospitalists Society.
These data presentations are provided by sanofi-aventis
U.S. LLC
55 Corporate Drive
Bridgewater, NJ 08807
1Deitelzweig.ASH.New OrleansLA.2009.2492[abstract]/p1/lines
36-37
2Amin.CHEST.SanDiegoCA.2009.Inpatient and outpatient
VTE prophylaxis/p2/Table/Line 2
3Geerts.CHEST.June.2008/p388S/c2/lines 30-33
4www.APHA.org.Deep-Vein Thrombosis: Advancing
Awareness to Protect Patient Lives/p1/lines 5-6
5Deitelzweig.ASH.New OrleansLA.2009.2492[abstract]/p1/lines
25-26
6Deitelzweig.ASH.New OrleansLA.2009.2492[abstract]/p1/lines
26-28
US.ENO.10.06.014 |
